Ads
related to: pharmaceutical drug companies
Search results
Recursion Pharmaceuticals’ (RXRX) Buy Rating Reiterated at Needham & Company LLC
ETF DAILY NEWS· 7 days agoNeedham & Company LLC reissued their buy rating on shares of Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) in a report issued on Friday morning, ...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 6 days agoAtea Pharmaceuticals, a biopharmaceutical company focused on developing therapeutics for viral...
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
WKRN Nashville· 5 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced ...
Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New...
Digital Journal· 17 hours agoUnion. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and...through ...
WHISTLEBLOWER ALLEGES GLAXOSMITHKLINE LIED ABOUT ZANTAC SAFETY CLAIMS
WFRV 5 Green Bay· 10 hours agoPHILADELPHIA, May 20, 2024 /PRNewswire/ -- Valisure LLC, a technology company that conducts independent chemical analysis of pharmaceuticals, filed an amended ...
Director Blake Borgeson Sells 20,054 Shares of Recursion Pharmaceuticals Inc (RXRX)
GuruFocus.com via Yahoo Finance· 4 days agoThe transaction was filed on the same day through an SEC Filing...transactions by the insider over...
High drug prices and pharmacy deserts: Protesters blame drug middlemen, demand regulation
USA TODAY via Yahoo News· 3 days agoThey also lowered...Caremark, owned by CVS Health; and OptumRx, owned by the same company as...
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk
Motley Fool via Yahoo Finance· 4 days agoOne particularly promising GLP-1 drug that investors should keep an eye out for is MariTide. Here's...
Parallel Bio launches Clinical Trial in a Dish to predict drug efficacy
Clinical Trials Arena via Yahoo Finance· 4 days agoUS-based biotech company Parallel Bio has introduced 'Clinical Trial in a Dish' to enhance...
BioMarin cutting about 170 jobs after shuffling drug portfolio - San Francisco Business Times
The Business Journals· 6 days agoRare-disease drug maker BioMarin Pharmaceutical Inc., whose new CEO last month outlined the shelving...
Ad
related to: pharmaceutical drug companies